The Current Ratio as of December 2025 (TTM) for Kyverna Therapeutics, Inc. (KYTX) is 5.39

According to Kyverna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.39. This represents a change of -32.53% compared to the average of 7.98 of the last 4 quarters.

Kyverna Therapeutics, Inc. (KYTX) Historical Current Ratio (quarterly & annually)

How has KYTX Current Ratio performed in the past?

The mean historical Current Ratio of Kyverna Therapeutics, Inc. over the last ten years is 5.24. The current 5.39 Current Ratio has changed 10.18% with respect to the historical average. Over the past ten years (40 quarters), KYTX's Current Ratio was at its highest in in the June 2023 quarter at 17.17. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Kyverna Therapeutics, Inc. (KYTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kyverna Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kyverna Therapeutics, Inc. (KYTX) Average Current Ratio

How has KYTX Current Ratio performed in the past?

The current Current Ratio of Kyverna Therapeutics, Inc. (KYTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kyverna Therapeutics, Inc. (KYTX) Current Ratio vs. Peers

How is KYTX’s Current Ratio compared to its peers?

Kyverna Therapeutics, Inc.’s Current Ratio is less than Allogene Therapeutics, Inc. (8.19), greater than Lexeo Therapeutics, Inc. Common Stock (4.43), greater than Cabaletta Bio, Inc. (3.60), less than Contineum Therapeutics, Inc. Class A Common Stock (29.07), greater than Editas Medicine, Inc. (2.77), less than Mereo BioPharma Group plc (8.13), less than Atea Pharmaceuticals, Inc. (19.17), greater than Capricor Therapeutics, Inc. (4.37), less than Lyell Immunopharma, Inc. (7.65), less than Silence Therapeutics plc (7.69),

Build a custom stock screener for Kyverna Therapeutics, Inc. (KYTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kyverna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kyverna Therapeutics, Inc. (KYTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kyverna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.